Clinical Trials Browser

OTHER × Locally Advanced HER2-negative Breast Cancer × Paclitaxel × Clear all

NCT01329627 2014-05-21

TAME-01

Phase 2 Terminated

Locally Advanced HER2-negative Breast Cancer